FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Medicalgorithmics's FCF Yield % or its related term are showing as below:
FRA:B8E'
s FCF Yield % Range Over the Past 10 Years
Min: -80.98 Med: -3.36 Max: 42.18
Current: -5.56
During the past 13 years, the highest FCF Yield % of Medicalgorithmics was 42.18%. The lowest was -80.98%. And the median was -3.36%.
FRA:B8E's FCF Yield % is ranked worse than 66.32% of 858
companies
in the Medical Devices & Instruments industry
Industry Median: -0.445
vs FRA:B8E: -5.56
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medicalgorithmics FCF Yield % Related Terms
Medicalgorithmics FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medicalgorithmics's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medicalgorithmics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicalgorithmics FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medicalgorithmics's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicalgorithmics (FRA:B8E) has a FCF Yield % of -5.56 as of Jul. 02, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medicalgorithmics and its competitors. According to the industry distribution chart, Medicalgorithmics ranks #569 out of 858 companies in the Medical Devices & Instruments industry, placing it in the top 66.3%.
Is Medicalgorithmics' FCF Yield % too high?
Medicalgorithmics' current FCF Yield % is -5.56. Based on the distribution chart, Medicalgorithmics ranks #569 out of 858 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medicalgorithmics has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medicalgorithmics ranks #569 out of 858 companies for FCF Yield %. This places Medicalgorithmics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medicalgorithmics and its competitors. Medicalgorithmics's current FCF Yield % is -5.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (FRA:B8E) has a current FCF Yield % of -5.56. The stock's GF Value™ is €6.00, compared to a current price of €5.94 — trading 1% below its estimated fair value. The current FCF Yield % is -5.56. Medicalgorithmics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medicalgorithmics (FRA:B8E), the current FCF Yield % is -5.56 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicalgorithmics (FRA:B8E) Overvalued in 2026?
Based on GuruFocus' analysis, Medicalgorithmics stock appears to be undervalued.
The current stock price of €5.94 is trading 1% below its estimated GF Value™ of €6.00.
Key valuation signals for FRA:B8E:
FCF Yield %: -5.56
GF Value™: €6.00 vs. price of €5.94 (1% below fair value)
No single metric tells the full story. See the FRA:B8E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score
Get the complete analysis for FRA:B8E
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:B8E has been successfully added to your 
